Brain and Neurological Disorders

OVERVIEW

The Brain and Neurological Disorders session offers an in-depth exploration of the latest advancements in brain and neurological disorders, focusing on the critical aspects of pathophysiology, diagnosis, and treatment. Attendees will gain valuable insights into the underlying mechanisms of conditions like Alzheimer’s and Parkinson’s disease, examining how genetic, environmental, and pathological factors contribute to these complex disorders. Understanding these mechanisms is essential for developing effective treatment strategies and improving patient outcomes.

The session will also highlight recent advancements in diagnostic techniques and biomarkers, showcasing how new imaging technologies and genetic testing are transforming the way we detect and monitor neurological disorders. By examining these innovations, participants will learn about the latest tools and methods that enhance diagnostic accuracy and facilitate early intervention, ultimately leading to more personalized and effective treatment approaches.

Interactive discussions and real-world case studies will be central to this session, providing participants with opportunities to engage with experts, explore practical applications of research findings, and share their own experiences. By examining current treatment strategies and future research directions, attendees will leave with a comprehensive understanding of the field and be better equipped to contribute to advancements in neurological science and clinical practice.

Overall, this session aims to provide a well-rounded view of brain and neurological disorders, combining theoretical knowledge with practical insights and interactive learning. It is an excellent opportunity for attendees to stay at the forefront of the field and engage with cutting-edge research and practices.

Key Topics:

Mechanisms and Etiology of Common Neurological Disorders
Advances in Diagnostic Techniques and Biomarkers
Emerging Therapies and Treatment Modalities
Case Studies: Real-world Applications and Outcomes
Future Directions in Neurological Research and Clinical Practice

TOPICS

Key Discussion Areas

Core scientific themes explored across all sessions in this track.

🔬

Interventional Cardiology Advances

Latest techniques in percutaneous coronary intervention, transcatheter structural interventions, and complex bifurcation stenting with outcome data from 2025–2026 trials.

💊

Heart Failure: New Drug Classes

Comprehensive review of SGLT2 inhibitors across HFrEF/HFpEF, mavacamten in HCM, and emerging agents in the pipeline with mechanisms and clinical trial evidence.

🤖

AI in Cardiac Imaging

Clinical validation data for AI tools in echocardiography, cardiac MRI, and CT angiography — including automated ejection fraction, plaque characterisation, and anomaly detection.

🧬

Cardiac Genetics & Cardiomyopathy

CRISPR applications in hereditary cardiomyopathy, genotype-guided risk stratification, and family screening protocols in hypertrophic and dilated cardiomyopathies.

⚡

Arrhythmia & Electrophysiology

Catheter ablation advances in persistent AF, ventricular tachycardia, and SCA prevention strategies including novel antiarrhythmic drug data and wearable monitoring.

🛡️

Preventive Cardiology

Polygenic risk scores in cardiovascular prevention, novel lipid-lowering strategies beyond statins, and population health approaches to primary cardiovascular prevention.

AUDIENCE

Who Should Attend?

This track is designed for clinicians, researchers, and allied health professionals with an interest in brain and neurological disorders.

Cardiologists and cardiology trainees
Interventional cardiologists
Cardiac electrophysiologists
Heart failure specialists
Cardiothoracic surgeons
Clinical cardiac physiologists
Internal medicine physicians with cardiovascular interest
Cardiovascular nurses and allied health professionals
Cardiovascular researchers and clinical trialists

Attend Brain and Neurological Disorders

Join delegates from 120+ countries for three days of world-class clinical science at the Healthcore Bridge International Medical Conference 2026.

FAQs

Frequently Asked Questions

What is the scope of the Oncology & Haematology track?

The Oncology & Haematology track covers precision oncology, immunotherapy, ADC therapies, haematological malignancies, liquid biopsy and early detection, AI in oncology, and palliative care — across 22 sessions over three conference days. It is the largest scientific track at the 2026 conference.

Will there be separate sessions for haematology and solid tumours?

Yes. The track is structured with dedicated morning sessions for haematological malignancies and afternoon sessions focusing on solid tumour oncology. The final panel each day brings all specialties together for cross-disciplinary discussion.

Are there oncology workshops available?

Yes. Two hands-on workshops complement the oncology track: a molecular tumour board simulation workshop and an AI pathology interpretation masterclass. Both require separate registration due to a 30-delegate capacity limit.

Is this track accredited for oncology-specific CME?

All oncology sessions are accredited for CME under EACCME, AMA PRA Category 1, and the Royal College of Radiologists (for radiation oncologists). Specialty-specific CME credit allocation is detailed in the conference programme and the CME pre-event delegate guide.